|
Published
|
Meeting
|
Title
|
Total: 7 |
03/2006 |
ACC
|
A New Perspective on the Contemporary Management of Acute Coronary Syndrome: Assessing New Evidence from ACC 2006
Presented and discussed by: SAMUEL Z. GOLDHABER, MD Originally presented by: Gregg W. Stone, MD, for the ACUITY Investigators
|
03/2005 |
ACC
|
You Cant Be Too Thin, Too Rich, or Too Low: The Treating to New Targets (TNT) Trial
Presented and discussed by: JOSHUA A. BECKMAN, MD, MS Originally presented by: John LaRosa, MD
|
11/2004 |
AHA
|
Do not delay! Send the patient to vascular surgery today! The CARP Trial
Presented and discussed by: JOSHUA A. BECKMAN MD, MS Originally presented by: Edward O. McFalls, MD, PhD
|
11/2004 |
AHA
|
The Case for Race versus Endothelial Dysfunction: The Combination of Isosorbide Dinitrate and Hydralazine in African-Americans with Heart Failure (The A-HeFT Trial)
Reported and discussed by: ANJU NOHRIA, M.D. Originally presented by: Jay N. Cohn, M.D. and Anne L. Taylor, M.D
|
06/2004 |
EMH
|
Outcomes in Hypertensive Patients at High Cardiovascular Risk treated with Regimens based on Valsartan or Amlodipine: The VALUE Randomized Trial
Reported and discussed by: PAUL R. CONLIN, M.D. Originally presented by: SE Kjeldsen, MD, S Julius, MD, and M Weber, MD
|
03/2004 |
ACC
|
Superior Yield of the New strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa inhibitors (SYNERGY) Trial
Presented and discussed by: ROBERT P. GIUGLIANO, MD, SM Originally presented by: KW MAHAFFEY, MD; JJ FERGUSON, MD; SG GOODMAN, MD; EJ TOPOL, MD; RM CALIFF, MD
|
03/2004 |
ACC
|
How Low Should You Go? The PROVE-IT TIMI 22 and ALLIANCE Trials
Presented and discussed by: JOSHUA A. BECKMAN, MD, MS Originally presented by: Christopher Cannon, M.D. (PROVE-ITTIMI-22), and Donald Hunninghake, M.D. (ALLIANCE)
|
Total: 7 |
|